Back to search
FDAFDA · Food and drugs·Recall number D-0753-2022

Orphenadrine Citrate Extended-Release Tablets, USP 100 mg, Rx Only, 100 Tablets, Manufactured by Sandoz Inc., Princeton, NJ 08540 NDC 0185-0022-01.

Published April 13, 2022 · Recall initiated: March 21, 2022

Summary

FDA records drug Class II recall D-0753-2022, published April 13, 2022 and initiated March 21, 2022. Recalling firm: Sandoz, Inc; Status: Terminated; Reported quantity: 7908 bottles(790,800 extended release tablets); Lot: Lot #: JX6411, JX6413, Exp. 05/2022 Lot #: KC0723,KC3303, Exp. 08/2022 Lot #: KE4348, KE7169,KE4349, Exp. 11/2022 Lot #: KL3199, KM0072,KS3939, Exp. 03/2023 Lot #: LA7704, LA7703,LA9243, Exp. 11/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations:Nitrosamine impurity (NMOA) above the acceptable daily limit.

What to do

Voluntary: Firm initiated · Press Release

Get an email if ORPHENADRINE CITRATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ORPHENADRINE CITRATE
Manufacturer
Sandoz, Inc
Distributor
Nationwide
Lot
Lot #: JX6411, JX6413, Exp. 05/2022 Lot #: KC0723,KC3303, Exp. 08/2022 Lot #: KE4348, KE7169,KE4349, Exp. 11/2022 Lot #: KL3199, KM0072,KS3939, Exp. 03/2023 Lot #: LA7704, LA7703,LA9243, Exp. 11/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Orphenadrine Citrate Extended-Release Tablets, USP 100 mg, Rx Only, 100 Tablets, Manufactured by Sandoz Inc., Princeton, NJ 08540 NDC 0185-0022-01. recalled?

Yes. FDA published recall D-0753-2022 on April 13, 2022. Reported hazard: CGMP Deviations:Nitrosamine impurity (NMOA) above the acceptable daily limit.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ORPHENADRINE CITRATE.